These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 31207601)

  • 1. The Prevalence of Mixed Hepatitis C Virus Genotype Infection and Its Effect on the Response to Direct-Acting Antivirals Therapy.
    Hayashi K; Tachi K; Shimizu Y; Nagano K; Ishizu Y; Kuzuya T; Honda T; Ishigami M; Hirooka Y; Hattori M; Goto H
    Intervirology; 2019; 62(1):23-29. PubMed ID: 31207601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origin, prevalence and response to therapy of hepatitis C virus genotype 2k/1b chimeras.
    Susser S; Dietz J; Schlevogt B; Zuckerman E; Barak M; Piazzolla V; Howe A; Hinrichsen H; Passmann S; Daniel R; Cornberg M; Mangia A; Zeuzem S; Sarrazin C
    J Hepatol; 2017 Oct; 67(4):680-686. PubMed ID: 28619439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of mixed infection by different hepatitis C virus genotypes in patients with hepatitis C virus-related chronic liver disease.
    Giannini C; Giannelli F; Monti M; Careccia G; Marrocchi ME; Laffi G; Gentilini P; Zignego AL
    J Lab Clin Med; 1999 Jul; 134(1):68-73. PubMed ID: 10402061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High HCV subtype heterogeneity in a chronically infected general population revealed by high-resolution hepatitis C virus subtyping.
    Rodriguez-Frias F; Nieto-Aponte L; Gregori J; Garcia-Cehic D; Casillas R; Tabernero D; Homs M; Blasi M; Vila M; Chen Q; Vargas V; Castells L; Viladomiu L; Genesca J; Minguez B; Augustin S; Riveiro-Barciela M; Carbonell J; Perales C; Soria ME; Asensio M; Llorens M; Ordeig L; Godoy C; Buti M; Esteban R; Pumarola T; Esteban JI; Quer J
    Clin Microbiol Infect; 2017 Oct; 23(10):775.e1-775.e6. PubMed ID: 28192235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of mixed genotype infections in Polish patients with hepatitis C.
    Gowin E; Bereszyńska I; Adamek A; Kowala-Piaskowska A; Mozer-Lisewska I; Wysocki J; Michalak M; Januszkiewicz-Lewandowska D
    Int J Infect Dis; 2016 Feb; 43():13-16. PubMed ID: 26701819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus genotypes in patients with chronic hepatitis C infection in southern Iran from 2016 to 2019.
    Namayandeh M; Jamalidoust M; Heydari Marandi N; Aliabadi N; Ziyaeyan A; Pouladfar G; Ziyaeyan M
    Microbiol Immunol; 2020 Nov; 64(11):762-767. PubMed ID: 32902892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus deep sequencing for sub-genotype identification in mixed infections: A real-life experience.
    Del Campo JA; Parra-Sánchez M; Figueruela B; García-Rey S; Quer J; Gregori J; Bernal S; Grande L; Palomares JC; Romero-Gómez M
    Int J Infect Dis; 2018 Feb; 67():114-117. PubMed ID: 29253705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?
    Pradat P; Pugliese P; Poizot-Martin I; Valantin MA; Cuzin L; Reynes J; Billaud E; Huleux T; Bani-Sadr F; Rey D; Frésard A; Jacomet C; Duvivier C; Cheret A; Hustache-Mathieu L; Hoen B; Cabié A; Cotte L;
    J Infect; 2017 Sep; 75(3):234-241. PubMed ID: 28579302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis C virus subgenotypes 1a and 1b in Japanese patients: ultra-deep sequencing analysis of HCV NS5B genotype-specific region.
    Wu S; Kanda T; Nakamoto S; Jiang X; Miyamura T; Nakatani SM; Ono SK; Takahashi-Nakaguchi A; Gonoi T; Yokosuka O
    PLoS One; 2013; 8(9):e73615. PubMed ID: 24069214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group.
    Zein NN; Rakela J; Krawitt EL; Reddy KR; Tominaga T; Persing DH
    Ann Intern Med; 1996 Oct; 125(8):634-9. PubMed ID: 8849147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misidentification of recombinant hepatitis C virus leading to treatment failure with direct acting antivirals.
    Mourez T; Decroos A; Goria O; Montialoux H; De Oliveira F; Larrat S; Plantier JC; Riachi G
    J Med Virol; 2018 May; 90(5):994-997. PubMed ID: 29350410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection in a tertiary care hospital in Mumbai, India: Identification of a mixed and novel genotype.
    Yabaji PM; Shankarkumar A; Shukla A; Bhatia S
    Indian J Med Microbiol; 2018; 36(3):352-356. PubMed ID: 30429386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of mixed genotype hepatitis C virus infections in the UK as determined by genotype-specific PCR and deep sequencing.
    McNaughton AL; Sreenu VB; Wilkie G; Gunson R; Templeton K; Leitch ECM
    J Viral Hepat; 2018 May; 25(5):524-534. PubMed ID: 29274184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Epidemiologic Data Regarding Hepatitis C Virus Infection in Romania.
    Manuc M; Preda CM; Popescu CP; Baicuș C; Voiosu T; Pop CS; Gheorghe L; Sporea I; Trifan A; Tanțău M; Tanțău A; Ceaușu E; Proca D; Constantinescu I; Ruta SM; Fulger LE; Diculescu M; Oproiu A
    J Gastrointestin Liver Dis; 2017 Dec; 26(4):381-386. PubMed ID: 29253053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of three patients with human immunodeficiency virus and hepatitis C virus genotype 1b co-infection by daclatasvir plus asunaprevir.
    Hirashima N; Iwase H; Shimada M; Ryuge N; Imamura J; Ikeda H; Tanaka Y; Matsumoto N; Okuse C; Itoh F; Yokomaku Y; Watanabe T
    Clin J Gastroenterol; 2017 Feb; 10(1):41-46. PubMed ID: 27766544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twelve-week ribavirin-free direct-acting antivirals for treatment-experienced Chinese with HCV genotype 1b infection including cirrhotic patients.
    Ji D; Chen GF; Wang C; Wang YD; Shao Q; Li B; Zhao J; You SL; Hu JH; Liu JL; Niu XX; Chen J; Lu L; Wu V; Lau G
    Hepatol Int; 2016 Sep; 10(5):789-98. PubMed ID: 27443347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and predictors of direct-acting antiviral treatment failure in Turkish patients with chronic hepatitis C genotype 1b infection.
    Cabalak M; Bal T; Onlen Y; Demir M
    Trop Doct; 2020 Apr; 50(2):141-146. PubMed ID: 31810415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders.
    Uemura H; Tsukada K; Mizushima D; Aoki T; Watanabe K; Kinai E; Teruya K; Gatanaga H; Kikuchi Y; Sugiyama M; Mizokami M; Oka S
    PLoS One; 2017; 12(10):e0186255. PubMed ID: 29045448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peginterferon alpha-2b plus ribavirin for chronic hepatitis C virus mixed genotype infection.
    Lin CC; Wu CH; Chen HL; Lin IT; Wang SY; Wang TE; Wang HY; Shih SC; Bair MJ
    Ann Hepatol; 2014; 13(4):350-5. PubMed ID: 24927605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the effect of interferon therapy and the change of hepatitis C virus non-structural 5B gene.
    Horiike N; Michitaka K; Masumoto T; Okura I; Akbar SM; Onji M
    J Gastroenterol Hepatol; 1999 Apr; 14(4):345-51. PubMed ID: 10207784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.